SMARTREND NEWS & MARKET ANALYSIS
SmarTrend analyzes over 5,000 stocks simultaneously on an intraday basis using its pattern recognition technology to give you real-time alerts for stocks on the move -- so you can maximize your trading results. Let our system increase your market awareness.
Trend Trade Your way to Success Today...Click HERE to Get Started on Your FREE 14-Day Trial!
Technical AnalysisBack to SmarTrend News & Market Analysis
Anadys Pharma (ANDS) Upgrade Alert, Watch for 8.5% Technical Downtrend Reversal - 11/3/2009 8:44:57 AM

By Chip Brian, SmarTrend Analytics Team
Twitter

Anadys Pharma (NASDAQ:ANDS) upgraded to Overweight from Neutral, $2.50 target, at Piper Jaffray. The stock closed yesterday at $1.84 on volume of 562,556 shares, above average daily volume of 0.

Anadys Pharmaceuticals is currently below its 50-day moving average of $2.42 and below its 200-day moving average of $3.51.

SmarTrend is bearish on shares of ANDS and our subscribers received a Downtrend alert on October 28, 2009 at $2.01, which has returned 8.5% to date.

Contact Chip Brian

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html

 

 



Comtex News Network, Inc. is not a registered investment advisor and does not provide investment advice.
Copyright Comtex News Network, Inc